Kozak & Associates, Inc. Organon & Co. Call Options Transaction History
Kozak & Associates, Inc.
- $482 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OGN
# of Institutions
796Shares Held
208MCall Options Held
2.74MPut Options Held
1.79M-
Black Rock Inc. New York, NY32.6MShares$219 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$217 Million0.01% of portfolio
-
State Street Corp Boston, MA9.52MShares$63.9 Million0.0% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.5MShares$63.8 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny9.09MShares$61 Million0.05% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $1.71B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...